WIRE: DEA lowers plant-derived medical cannabis to Schedule V
Washington, DC — The US Drug Enforcement Administration has classified Epidiolex, a prescription medicine containing a standardized formulation of plant-derived [...]
DEA
WIRE: DEA reports uptick in marijuana seizures in 2016
Washington, DC — Seizures of indoor and outdoor cannabis crops reported by the US Drug Enforcement Administration rose in 2016, according to annual data compiled by [...]
WIRE: Weed for Warriors project asks Sessions to expedite research marijuana supply
Nevada — The Weed for Warriors Project has submitted a letter addressed to The Attorney General of the United States, The Honorable Jeff Sessions, asking him to [...]
WIRE: DEA to classify liquid, synthetic THC as Schedule II drug
Washington, DC — Officials from the US Drug Enforcement Administration (DEA) have recommended that Syndros, a liquid form of synthetic THC, be classified as a Schedule [...]
WIRE: ASA urges Congress to stop using false cannabis information
Washington, DC — Today, Americans for Safe Access, a national nonprofit dedicated to ensuring safe and legal access to medical cannabis for therapeutic use and research, [...]
WIRE: DEA removes marijuana misinformation from website after public pressure
WASHINGTON DC — After months of public pressure, the Drug Enforcement Administration (DEA) has removed factually inaccurate information from its website. The change comes [...]
WIRE: More than 70,000 sign petition for DEA to stop spreading misinformation about cannabis
WASHINGTON, DC — In a new petition from Americans for Safe Access and Change.org, over 70,000 people are calling on the Drug Enforcement Administration to stop [...]
WIRE: NORML releases 2016 cannabis top 10 Year in Review stories
NORML’s top 10 events that shaped cannabis policy in 2016 #1 Adult Use Marijuana Laws Win Big on Election Day Voters in eight states on Election Day decided in favor of [...]
WIRE: Business group says DEA rescheduling of CBD is irrational and irresponsible
DENVER — The Cannabis Business Alliance (CBA) has released a statement on the recent reports of the United States Drug Enforcement Administration’s rescheduling of all [...]
WIRE: DEA enacts final rule making cannabis extracts, CBD a Schedule 1 drug
DENVER, CO – On December 13, 2016, the DEA issued its Final Rule, “Establishment of New Drug Code for Marihuana Extract,” which serves to potentially [...]